Literature DB >> 18779411

Disease anticipation in familial myeloproliferative neoplasms.

Elisa Rumi, Francesco Passamonti, Cristina Picone, Matteo Giovanni Della Porta, Cristiana Pascutto, Mario Cazzola, Mario Lazzarino.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18779411     DOI： 10.1182/blood-2008-05-160739

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  5 in total

1.  Familial risks of acute myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms.

Authors:  Amit Sud; Subhayan Chattopadhyay; Hauke Thomsen; Kristina Sundquist; Jan Sundquist; Richard S Houlston; Kari Hemminki
Journal:  Blood       Date:  2018-07-10       Impact factor: 22.113

2.  The role of the JAK2 GGCC haplotype and the TET2 gene in familial myeloproliferative neoplasms.

Authors:  Damla Olcaydu; Elisa Rumi; Ashot Harutyunyan; Francesco Passamonti; Daniela Pietra; Cristiana Pascutto; Tiina Berg; Roland Jäger; Emma Hammond; Mario Cazzola; Robert Kralovics
Journal:  Haematologica       Date:  2010-12-20       Impact factor: 9.941

3.  JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms.

Authors:  Amy V Jones; Andrew Chase; Richard T Silver; David Oscier; Katerina Zoi; Y Lynn Wang; Holger Cario; Heike L Pahl; Andrew Collins; Andreas Reiter; Francis Grand; Nicholas C P Cross
Journal:  Nat Genet       Date:  2009-03-15       Impact factor: 38.330

4.  Germline and somatic JAK2 mutations and susceptibility to chronic myeloproliferative neoplasms.

Authors:  Lynn R Goldin; Magnus Björkholm; Sigurdur Y Kristinsson; Jan Samuelsson; Ola Landgren
Journal:  Genome Med       Date:  2009-05-29       Impact factor: 11.117

Review 5.  Post-ET and Post-PV Myelofibrosis: Updates on a Distinct Prognosis from Primary Myelofibrosis.

Authors:  Francesco Passamonti; Barbara Mora; Daniela Barraco; Margherita Maffioli
Journal:  Curr Hematol Malig Rep       Date:  2018-06       Impact factor: 3.952
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.